SecBot SecBot

ANVS

Annovis Bio, Inc.
NYSE· Pharmaceutical Preparations· Inc. DE· CIK 0001477845 Biotech & Drug Discovery
$0.7500 −0.18 (−19.35%)
Nov 16 4:00 PM ET · prev $0.9300
Market cap
$57.2M
Micro cap
Consensus
Buy
90% Buy or better · 10 analysts
Median target
🔒 Subscribers only
1 year
−75.2%
from $3.03 · Nov 17
30 days
−21.9%
from $0.9600
52-week range
$0.6700–5.10
−85% from high · low Nov 5
Avg volume 20D
3.46M
Nov 5 spike 30.87M
Short interest
5.36M
≈8.4% of shares · −6.4%
Days to cover
6.8
at average volume
Insider net
+$6.6M
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
15
analyzed by SecBot
SecBot read BEARISH 11 reports · 90 days
Balance 7 bearish · 0 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 10/11

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $6.6M at an average $1.15. No open-market sales. Price is 35% below their cost.

  • InstitutionsBULLISH

    Q3 2026: 9 added (0 new), 2 trimmed or exited.

  • AnalystsBULLISH

    9 of 10 rate it Buy or better.

  • Short sellersSTEADY

    Short interest −6.4% to 5.36M shares. 6.8 days to cover, ≈8.4% of shares.

  • TrendDOWNTREND

    31% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 5.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCTRIM736,027$934.8K
VANGUARD FIDUCIARY TRUST COADD224,236$284.8K
MORGAN STANLEYDOUBLED199,351$253.2K
UBS Group AGDOUBLED114,602$145.5K
STATE STREET CORPADD105,335$133.8K
JPMORGAN CHASE & COADD19,900$25.9K
OSAIC HOLDINGS, INC.DOUBLED6,640$8.4K
PNC FINANCIAL SERVICES GROUP, INC.DOUBLED2,960$3.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Buy 90% rate it Buy or better
Strong Buy2Buy7Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
REITERATE
REITERATE
Aug 28, 2026Roth Capital
MAINTAIN
MAINTAINBuy
Aug 18, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Jul 8, 2026Roth Capital
INITIATE
INITIATEBuy

Insider ledger

Form 4
$6.6M
bought · 1 insider
$0
sold · 0 insiders
−34.6%
vs their $1.15 cost
DateInsiderTypeValue
Nov 6, 2026
Hoffman Michael B
Director
Nov 6, 2026
BUY5,000,000 sh
Nov 6, 2026
Hoffman Michael B
Director
Nov 6, 2026
BUY$5.0M
May 20, 2026
Hoffman Michael B
Director
May 20, 2026
BUY$104.4K
May 20, 2026
Hoffman Michael B
Director
May 20, 2026
BUY$33.9K
May 20, 2026
Hoffman Michael B
Director
May 20, 2026
BUY$4.5K
Apr 2, 2026
Hoffman Michael B
Director
Apr 2, 2026
BUY$1.5M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Reddit
Recent posts
All social signals and their track records

Short side

FINRA· Oct 30, 2026
5,356,098
shares short
-6.4%
vs prior settlement
6.8
days to cover
≈8.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

SecBot reports

15 filings · 4 press releases · 0 bullish · 8 bearish · 2 mixed · 5 neutral
All ANVS filing & press-release reports (19)